Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Clinical trial NCT00565227 · TERMINATED

Trial details

NCT number: NCT00565227
Sponsor: University of Michigan Rogel Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma Prostate Cancer Bladder Cancer Urothelial Carcinoma

Start date: 2007-04-01
Primary completion: 2008-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.